Erythrocytes as carriers of anthracycline antibiotics


Cite item

Full Text

Full Text

Эритроциты - переносчики антрациклиновых антибиотиков. -
×

References

  1. Lee Y.-T. N., Chan К. К., Harris P. A. et al. Distribution of adriamycin in cancer patients. Tissue uptakes, plasma concentration after hepatic IA administration. Cancer (Philand.) 1980; 45: 2231-2239.
  2. Richardson D. S., Johnson S. A. Anthracyclines in haematology: preclinical studies, toxicity and delivery systems. Blood Rev. 1997; 11: 201-223.
  3. Shan K., Lincoff A. M., Young J. B. Anthracycline-induced cardiotoxicity. Ann. Intern. Med. 1996; 125 (1): 47-58.
  4. Ostro M. J., Cullis P. R. Use of liposomes as injectable-drug delivery systems. Am. J. Hosp. Pharm. 1989; 46: 1576-1587.
  5. Woodle M. C., Lasic D. D. Sterically stabilized liposomes. Biochim. Biophys. Acta 1992; 1113: 171-199.
  6. Poznansky M. J., Juliano R. L. Biological approaches to the controlled delivery of drugs: a critical review. Pharmacol. Rev. 1984; 36 (4): 277-336.
  7. Gill P. S., Espina В. M., Muggia F. et al. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J. Clin. Oncol. 1995; 13: 996-1003.
  8. Pea F., Russo D., Michieli M. et al. Liposomal daunorubicin plasmatic and renal deposition in patients with acute leukemia. Cancer Chemother. Pharmacol. 2000; 46: 279-286.
  9. Gabizon A., Catane R., Uziely B. et al. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res. 1994; 54: 987-992.
  10. Lim H. J., Masin D., Madden T. D., Bally M. B. Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone. J. Pharmacol. Exp. Ther. 1997; 28: 566-573.
  11. Millan C. G., Marinero M. L. S., Castaneda A. Z., Lanao J. M. Drug, enzyme and peptide delivery using erythrocytes as carriers. J. Control. Release 2004; 95: 27-49.
  12. Ihler G. M. Erythrocyte carriers. Pharmacol. and Ther. 1983; 20: 151-169.
  13. Saulis G. The loading of human erythrocytes with small molecules by electroporation. Cell Mol. Biol. Lett. 2005; 10: 23-35.
  14. Kitao Т., Hattori К. Erythrocyte entrapment of daunomycin by amphotericin В without hemolysis. Cancer Res. 1980; 40: 1351-1353.
  15. Kitao Т., Hattori K., Takeshita M. Agglutination of leukemic cells and daunomycin entrapped erythrocytes with lectin in vitro and in vivo. Experientia 1978; 34: 94-95.
  16. Ataullakhanov F. I., Vitvitsky V. M., Kovaleva V. L. Rubomycin loaded erythrocytes in the treatment of mouse tumor P388. In: Magnani M., DeLoach J. R. The use of resealed erythrocytes as carriers and bioreactors. New York: Plenum Press; 1992. 209-213.
  17. Ataullakhanov F. I., Batasheva Т. V., Bukhman V. M. et al. Treatment of Rausher virus induced murine erythroblastic leukemia with rubomycin loaded erythrocytes. Adv. Biosci. 1994; 92: 177-183.
  18. Атауллаханов Ф. И., Баташева Т. В., Витвицкий В. М. и др. Влияние обработки глютаровым альдегидом на выход рубомицина и гемоглобина из нагруженных рубомицином мышиных эритроцитов. Биотехнология 1993; 2: 40-43.
  19. Tonetti М., Zocchi Е., Guida Z. et al. Use of glutaraldehyde treated autologous human erythrocytes for hepatic targeting of doxorubicin. In: Magnani M., DeLoach J. R. The use of resealed erythrocytes as carriers and bioreactors. New York: Plenum Press; 1992. 307-317.
  20. Zocchi E., Tonetti M., Polvani C. et al. In vivo liver and lung targeting of adriamycin encapsulated in glutaraldehyde-treated murine erythrocytes. Biotechnol. Appl. Biochem. 1988; 10: 555-562.
  21. Ataullakhanov F. I., Kulikova E. V., Vitvitsky V. M. Doxorubicin binding by human erythrocytes. In: DeLoach J. R., Way J. L. Carrier and bioreactor red blood cells for drug delivery and targeting. Kidlington: Elsevier Science; 1994. 163-168.
  22. Скороход А. А., Витвицкий В. M., Кульман Р. А. и др. Повреждающее воздействие рубомицина и доксорубицина на эритроциты человека in vitro. Вопр. онкол. 1999; 4: 374-379.
  23. О совершенствовании деятельности учреждений службы крови в условиях нового хозяйственного механизма: Приказ МЗ СССР № 155 от 12.04.1990 г. М.; 1990.
  24. Skorokhod О. A., Garmaeva Т. Т., Vitvitsky V. М. et al. Pharmacokinetics of erythrocyte-bound daunorubicin in patients with acute leukemia. Med. Sci. Monit. 2004; 10 (4): 155-164.
  25. Вуймо Т. А., Куликова E. В., Синауридзе E. И. и др. Создание новой лекарственной формы антрациклинового антибиотика митоксантрона путем включения его в эритроциты. Молекул. мед. 2008; 2.
  26. Ataullakhanov F. I., Isaev V. G., Kohno A. V. Pharmacokinetics of doxorubicin in patients with lymphoproliferative disorders after infusion of doxorubicin-loaded erythrocytes. In: Sprandel U., Way J. L., eds. Erythrocytes as drug carriers in medicine. New York: Plenum Press; 1997. 137-142.
  27. Куликова E. В., Витвицкий В. M., Кохно А. В. и др. Введение эритроцитов, нагруженных доксорубицином, больным с лимфопролиферативными заболеваниями. Гематол. и трансфузиол. 1998; 4: 26-29.
  28. Исаев В. Г., Гармаева Т. Ц., Скороход А. А. и др. Применение иммобилизованных форм даунорубицина у больных острыми лейкозами. Тер. арх. 1999; 10: 32-37.
  29. Skorokhod A. A., Kulikova Е. V., Galkina N. М. et al. Doxorubicin pharmacokinetics in lymphoma patients treated with doxorubicin-loaded erythrocytes. Haematologica 2007; 92: 570-571.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2008 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies